Synergy CHC faces Nasdaq $1 bid-price deficiency
Synergy CHC Corp. received a non-compliance notice from Nasdaq after its common stock closed below $1.00 per share for 30 consecutive business days, violating the Nasdaq Capital Market minimum bid price rule.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Synergy CHC Corp. received a non-compliance notice from Nasdaq after its common stock closed below $1.00 per share for 30 consecutive business days, violating the Nasdaq Capital Market minimum bid price rule.
The company has 180 calendar days, until November 11, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for 10 straight business days. If it meets other Nasdaq listing standards, it may qualify for an additional 180-day grace period. Failing to regain compliance could lead to delisting, and management is monitoring the share price and may consider options such as a reverse stock split.
Positive
- None.
Negative
- Nasdaq minimum bid-price violation and delisting risk: Synergy CHC’s shares traded below the $1.00 minimum bid for 30 consecutive business days, starting a 180-day cure period and creating the possibility of Nasdaq delisting if compliance is not restored.
Insights
Nasdaq bid-price noncompliance introduces delisting risk for Synergy CHC.
Synergy CHC Corp. has fallen below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days, triggering a formal non-compliance notice. The stock remains listed for now, but this places the company on a defined remediation timeline under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A).
The company has 180 days, until November 11, 2026, to record a closing bid of at least $1.00 for 10 consecutive sessions. If it satisfies all other initial listing standards, it may obtain a second 180-day period by committing to a cure plan, potentially including a reverse stock split.
If compliance is not restored within the available period(s), Nasdaq may move to delist the shares, shifting trading to less regulated venues. Actual impact will depend on future price performance and any corporate actions the board elects to pursue.
8-K Event Classification
Key Figures
Key Terms
Minimum Bid Price Requirement financial
Nasdaq Listing Rule 5550(a)(2) regulatory
Nasdaq Listing Rule 5810(c)(3)(A) regulatory
Nasdaq Capital Market financial
reverse stock split financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq notice did Synergy CHC Corp. (SNYR) receive?
How long does Synergy CHC have to regain Nasdaq bid-price compliance?
Can Synergy CHC get more time beyond November 11, 2026 to fix compliance?
What happens if Synergy CHC fails to regain Nasdaq compliance?
Is Synergy CHC considering a reverse stock split to meet Nasdaq rules?
AI-generated analysis. How Rhea-AI works. Not financial advice.